DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 52-Week Low – Time to Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s stock price reached a new 52-week low on Friday . The company traded as low as $10.52 and last traded at $10.5750, with a volume of 834181 shares changing hands. The stock had previously closed at $10.95.

Analyst Upgrades and Downgrades

XRAY has been the topic of several analyst reports. Wells Fargo & Company reduced their target price on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Stifel Nicolaus set a $13.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, November 6th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Price Performance

The firm has a market cap of $2.10 billion, a P/E ratio of -2.22, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The business has a 50-day moving average of $12.65 and a two-hundred day moving average of $14.38.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several large investors have recently modified their holdings of XRAY. Envestnet Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA by 9.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock valued at $7,391,000 after buying an additional 40,936 shares during the period. Bank of Montreal Can grew its position in DENTSPLY SIRONA by 8.2% in the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after purchasing an additional 26,610 shares during the period. Envestnet Portfolio Solutions Inc. increased its stake in DENTSPLY SIRONA by 36.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 15,460 shares of the medical instruments supplier’s stock valued at $246,000 after purchasing an additional 4,165 shares in the last quarter. AGF Management Ltd. raised its holdings in DENTSPLY SIRONA by 29.6% during the second quarter. AGF Management Ltd. now owns 186,424 shares of the medical instruments supplier’s stock worth $2,960,000 after buying an additional 42,542 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at about $366,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.